• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » MiMedx can’t recover $40M from former execs

MiMedx can’t recover $40M from former execs

May 25, 2021 By Nancy Crotti

MiMedx MiMedxcannot recoup $40.2 million from two former executives convicted in a scheme to defraud the company and its investors, a federal judge has ruled.

“MiMedx is not a “victim” under federal law and is therefore not entitled to recover restitution from either man, Manhattan U.S. District Court Judge Jed Rakoff wrote in a ruling issued on Sunday.

In November 2020, a Manhattan jury found that former CEO Parker Petit, 81, and former COO Taylor, 52, had entered into undisclosed side arrangements with five distributors. These arrangements allowed distributors to return product to Marietta, Ga.–based MiMedx or conditioned distributors’ payment obligations on sales to end-users, the government charged. Petit was convicted of securities fraud, and Taylor was convicted of conspiracy to commit securities fraud, to make false statements in SEC filings and to mislead the conduct of audits.

Petit and William Taylor were each sentenced in February to one year in prison for their involvement in the scheme to fraudulently inflate the company’s reported revenue in 2015 and 2016. Petit was also fined $1 million and Taylor $250,000.

“Although they were undoubtedly also motivated by personal financial gain, “the defendants’ criminal actions were within the scope of their employment and designed to benefit MiMedx” by inflation its stock price, Rakoff added.  “Thus, MiMedx could have been — but ultimately was not — criminally charged as a result of the defendants’ conduct. Accordingly, the court holds that MiMedx is a not victim under the restitution statutes.”

However, MiMedx can still recover some of the losses it incurred, the judge noted. The company is suing both ex-execs in federal court in Florida to, among other things, recoup the fees paid to the defendants’ counsel to defend them in this case, he wrote.

This federal court case in Manhattan “remains an open legal matter and next steps are still being determined,” the company said in an email to MassDevice.

Filed Under: Business/Financial News, Featured, Legal News Tagged With: MiMedx Group Inc.

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy